Related Experiment Video
Updated: May 26, 2026
07:07
Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice
Published on: June 27, 2020
Fighting against infectious diseases in China
1Sinovac, Beijing, China. yinwd@sinovac.com
Human Vaccines
|December 22, 2011
Summary
Dr. Yin pioneered infectious disease research, developing China's first inactivated hepatitis A vaccine in 2002. His work led to vaccines for SARS, H5N1, H1N1, and other diseases.
Area of Science:
- Infectious Disease Prevention
- Vaccinology
- Virology
Background:
- Dr. Yin's research in infectious disease prevention began in the 1980s.
- Significant milestone: isolation of the hepatitis A virus in 1985.
- Development of China's first proprietary inactivated hepatitis A vaccine in 2002.
Purpose of the Study:
- To document the development of key vaccines led by Dr. Yin.
- To highlight Sinovac's vaccine research and development pipeline.
- To emphasize the goal of providing high-quality vaccines domestically and globally.
Main Methods:
- Historical research and development documentation.
- Vaccine development and market launch analysis.
- Research and Development (R&D) in novel vaccine candidates.
Main Results:
- Successful isolation of the hepatitis A virus in 1985.
- Development and market launch of the first inactivated hepatitis A vaccine in China (2002).
- Creation of vaccines for SARS, H5N1, H1N1, hepatitis A, hepatitis B, and influenza.
Conclusions:
- Dr. Yin's leadership has been instrumental in advancing vaccine development in China.
- Sinovac's R&D efforts continue with vaccines for EV71 and pneumococcal disease.
- The company aims to deliver internationally recognized vaccines for children worldwide.
Related Concept Videos
01:20Infection
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:24iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
01:18Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis: